Remote monitoring for early cardiogenic shock recovery
Part of Heart & circulation clinical trials.
This trial tests whether digital out-of-hospital management improves outcomes for patients who have recovered from early-stage cardiogenic shock. If you have been discharged after treatment for this condition and can use a smartphone, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You were in the hospital with early cardiogenic shock (SCAI stage A, B, or C) and have stable symptoms at discharge.
- You can use a smartphone for health management after training.
- You have not had a cardiac arrest or heart surgery before.
- Your heart function (LVEF) is 30% or higher and your kidney function is adequate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
This trial tests a digital health tool to help manage heart failure medications after you leave the hospital. If you were recently hospitalized for heart failure and have a smartphone or tablet, you may be able to join.
This trial tests a remote education and support program to help people recover after a heart attack using digital tools from home, instead of in-person visits. It may be a good fit if you are comfortable with technology and live in Manitoba.
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
This trial tests whether setting a personalized blood pressure goal for each person in cardiogenic shock improves recovery compared to standard care. It may help if you have severe shock and can be enrolled within the first 24 hours.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.